Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2014111136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

IL-18 Production From the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2016English

17 -Estradiol Replacement Improves Renal Function and Pathology Associated With Diabetic Nephropathy

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2005English

Significance of IL-6 and IL-17 Cytokines in Diagnostics and Prognosis of the Metabolic Syndrome

Medical and Health Science Journal
2013English

Differential Effects of Low-Dose Erythropoietin in Rat Model of Diabetic Nephropathy

Advances in Medicine and Medical Research
2018English

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2007English

Glycosaminoglycans in Therapy of Diabetic Nephropathy

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
1996English

Diabetic Nephropathy: The Role of Inflammation in Fibroblast Activation and Kidney Fibrosis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2013English

CD8+ IL-17 Responses and Obliterative Airway Disease Persist in T-Bet-/- Mouse Recipients of Lung Transplant Treated With Low Dose Azithromycin Therapy

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy